-
-
Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres
-
An update on trials of novel lipid-lowering drugs.
-
An update on trials of novel lipid-lowering drugs
-
An audit of the effectiveness of PCSK9 inhibition in reducing cholesterol in patients attending lipid clinics